REGENXBIO Inc. financial data

Symbol
RGNX on Nasdaq
Location
9804 Medical Center Drive, Rockville, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 286 % -9.31%
Debt-to-equity 127 % +82.7%
Return On Equity -78.3 % -10.8%
Return On Assets -34.5 % +17.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.6M shares +2.18%
Common Stock, Shares, Outstanding 50.6M shares +2.19%
Entity Public Float 536M USD -33.4%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 51.7M shares +1.75%
Weighted Average Number of Shares Outstanding, Diluted 51.7M shares +1.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 161M USD +91.3%
Research and Development Expense 219M USD +2.45%
General and Administrative Expense 80.5M USD +6.46%
Costs and Expenses 316M USD -4.23%
Operating Income (Loss) -155M USD +37%
Nonoperating Income (Expense) -23M USD -432%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -264M USD +5.98%
Net Income (Loss) Attributable to Parent -178M USD +25.5%
Earnings Per Share, Basic -3 USD/shares +31.3%
Earnings Per Share, Diluted -3 USD/shares +31.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.8M USD +3.86%
Marketable Securities, Current 215M USD +8.33%
Cash, Cash Equivalents, and Short-term Investments 302M USD +8.4%
Accounts Receivable, after Allowance for Credit Loss, Current 25.3M USD +7.38%
Other Assets, Current 19.5M USD +21.1%
Assets, Current 332M USD +5.93%
Property, Plant and Equipment, Net 108M USD -10.8%
Operating Lease, Right-of-Use Asset 48.8M USD -11.7%
Other Assets, Noncurrent 4.27M USD -1.48%
Assets 525M USD +1.17%
Accounts Payable, Current 22.3M USD +14.1%
Employee-related Liabilities, Current 15.1M USD +5.17%
Contract with Customer, Liability, Current 13.2M USD +9063%
Liabilities, Current 125M USD +21.3%
Contract with Customer, Liability, Noncurrent 21.2M USD
Operating Lease, Liability, Noncurrent 67.4M USD -11.7%
Other Liabilities, Noncurrent 648K USD -81.9%
Liabilities 364M USD +67.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -652K USD -12%
Retained Earnings (Accumulated Deficit) -1.06B USD -20.2%
Stockholders' Equity Attributable to Parent 161M USD -46.4%
Liabilities and Equity 525M USD +1.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 33.6M USD
Net Cash Provided by (Used in) Financing Activities -5.79M USD -105%
Net Cash Provided by (Used in) Investing Activities 44.7M USD +239%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 50.6M shares +2.19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 72.6M USD -7.49%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 60.8M USD +3.73%
Deferred Tax Assets, Valuation Allowance 338M USD +20.6%
Deferred Tax Assets, Gross 377M USD +16.5%
Operating Lease, Liability 82M USD -8.13%
Payments to Acquire Property, Plant, and Equipment 1.02M USD +83.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -178M USD +23.3%
Lessee, Operating Lease, Liability, to be Paid 110M USD -9.89%
Property, Plant and Equipment, Gross 191M USD +0.61%
Operating Lease, Liability, Current 9.07M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.9M USD +1.06%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.3M USD +3.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.2M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10M USD -20.9%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +70.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 100K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.94M USD -20.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 38.7M USD -10.6%
Share-based Payment Arrangement, Expense 35.7M USD -4.1%
Interest Expense 5.41M USD -61.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%